Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matija Snuderl

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
JAMA Oncology|July 9, 2026
Global Consensus on the Management of Primary Localized ChordomaStefano Radaelli, Anna M Frezza, Piero Fossati, et al.
Nature Communications|November 28, 2022
DNA methylation-based classification of sinonasal tumorsPhilipp Jurmeister, Stefanie Glöß, Renée Roller, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|August 21, 2021
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumKaram T Alhalabi, Damian Stichel, Philipp Sievers, et al.
Neuro-Oncology|June 2, 2021
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective studyKatja von Hoff, Christine Haberler, Felix Schmitt-Hoffner, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively ValidatedSybren L N Maas, Damian Stichel, Thomas Hielscher, et al.
JAMA Oncology|July 9, 2026
Global Consensus on the Management of Primary Localized ChordomaStefano Radaelli, Anna M Frezza, Piero Fossati, et al.
Nature Communications|November 28, 2022
DNA methylation-based classification of sinonasal tumorsPhilipp Jurmeister, Stefanie Glöß, Renée Roller, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Pageof 27